Ribon | search
Click here to view Ribon news from 60+ newspapers.
Bookmark or Share- Baskin-RobbinsEscape to the fairytale forest this fall with our Creature Creations®! Choose from an Elf, Dragon, or Wizard, pick your favorite flavor, and get a crown to match your creature! Order Now. Gather around the table for our flavorful fall cakes, the perfect addition for any autumn occasion. Customize with your favorite flavors to savor the season.
- Ribon, backed by biopharma majors, raises $65M to take PARP7 ...Ribon Therapeutics has raised $65 million to advance a pipeline led by a PARP7 inhibitor deeper into the clinic. The financing positions Ribon to build on work to target stress support pathways...
- ONO enters into License Agreement with Ribon Therapeutics for ...Ribon Therapeutics is a clinical stage biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions that contribute to disease.
- Big Pharma-Backed Ribon Therapeutics Shuts Down Business ...Founded in 2015, Ribon was a clinical-stage biotech that was advancing three PARP inhibitors for various indications. Its most mature candidate was RBN-2397, which the company was developing for squamous cell lung carcinoma in combination with Merck’s Keytruda (pembrolizumab).
- Ribon - WikipediaRibon (りぼん, lit. "Ribbon") is a monthly Japanese shōjo manga magazine published by Shueisha on the third of each month. First issued in August 1955, its rivals are Nakayoshi and Ciao. It is one of the best-selling shōjo manga magazines, having sold over 590 million copies since 1978.
More
